1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Sundrug Co.,Ltd.

Sundrug Co.,Ltd.

SDGCF
Sundrug Co.,Ltd.US flagOther OTC
28.18
USD
- -
- -
3.30BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
3,552.81
3,636.91
4,167.39
4,472.44
4,824.44
5,031.06
5,284.59
5,426.09
5,548.64
5,905.26
6,428.8
6,855.27
7,202.29
3,249.62
Basic EPS, GAAP
124.99
133.48
178.43
197.32
212.31
204.75
202.67
216.67
204.02
219.83
249.07
262.9
268.36
128.87
Free Cash Flow per Basic Share
192.96
19.14
202.29
142.74
202.54
170.22
179.39
130.76
101.72
96.36
25.34
58.98
103.96
- -
Dividend per Share
25.99
30.21
34.97
45.28
54.46
65.99
67.26
68.98
70.02
85.98
106.99
121.97
129.96
- -
Book Value per Share
893.72
1,022.68
1,180.47
1,359.89
1,531.62
1,461.35
1,596.88
1,744.55
1,873.76
2,006.35
2,148.15
2,288.64
2,426.01
2,212.83
Tangible Book Value per Share
861.95
907.19
1,062.45
1,114.15
1,283.36
1,423.72
1,554.25
1,709.6
1,835.81
1,943.35
2,086.1
2,231.87
2,375.66
2,153.76
Basic Weighted Avg Shares
126
123
121
118
117
117
117
117
117
117
117
117
117
117
Sales/Revenue/Turnover
447,819
445,818
503,773
528,394
564,215
588,069
617,769
634,310
648,734
690,462
751,777
801,811
842,512
380,070
Operating Margin (%)
6.27
5.82
6.56
6.45
6.4
5.99
5.93
5.89
5.25
5.42
5.45
5.55
5.56
5.37
Depreciation Expense
5,609
6,225
6,419
6,972
7,788
8,242
8,359
8,663
10,209
12,068
15,127
17,282
18,760
- -
Net Income, GAAP
15,754
16,362
21,569
23,312
24,829
23,933
23,692
25,329
23,853
25,703
29,126
30,750
31,392
15,072
Effective Tax Rate (%)
42.03
38.42
35.18
32.28
32.15
31.76
31.62
31.89
31.21
31.84
29.41
29.42
31.46
27.07
Profit Margin (%)
3.52
3.67
4.28
4.41
4.4
4.07
3.84
3.99
3.68
3.72
3.87
3.84
3.73
3.97
Working Capital
48,053
45,603
58,753
55,367
65,471
78,095
90,770
99,146
103,492
92,658
52,777
88,270
104,029
86,098
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
33,866
42,076
30,916
Total Equity
113,205
115,987
133,285
136,335
154,828
171,055
186,821
205,155
220,592
236,327
253,089
269,714
286,001
260,760
Return on Invested Capital (%)
14.25
13.23
16.36
16.3
16.09
14.17
13.51
12.52
10.68
10.86
10.72
10.26
9.74
5.37
Return on Capital (%)
14.67
13.71
16.1
15.37
14.62
13.68
13.26
12.97
11.28
11.34
11.19
10.42
9.92
5.63
Return on Common Equity (%)
14.8
13.75
16.09
15.37
14.61
13.68
13.25
12.97
11.28
11.33
11.99
11.85
11.38
6.01

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
35,000
- -
3,500
LT Borrowings
- -
- -
30,916
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
117
- -
117
Market Capitalization
432,065
530,567
473,750

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
208,243
- -
202,587
Cash, Cash Equivalents & STI
69,698
- -
63,394
Accounts Receivable, Net
26,740
- -
24,677
Inventories
91,292
- -
93,110
Total Current Liabilities
155,466
- -
116,489
Payables & Accruals
- -
- -
- -
ST Debt
35,000
- -
3,500
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.97%
6.87%
6.04%
Free Cash Flow
7.97%
21.59%
76.3%
Net Income, GAAP
3.98%
4.58%
2.09%
Sales/Revenue/Turnover
5.29%
5.86%
5.08%
Total Cash Common Dividend
14.06%
13.87%
6.56%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
182,146
189,561
194,265
185,805
751,777
2025
- -
- -
- -
- -
801,811
2026
- -
- -
- -
- -
842,512

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
59.01
- -
- -
- -
249.07
2025
- -
- -
- -
- -
262.9
2026
- -
- -
- -
- -
268.36

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
106.99
2025
- -
- -
- -
- -
121.97
2026
- -
- -
- -
- -
129.96

Company Description

APIChatGPT
CEO
Hiroshi Sadakata
Full Time Employees
7,457
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Address
1-38-1, Wakamatsucho Fuchu TY Japan 183-0005
IPO Date
Oct 24, 2014
Website
sundrug.co.jp
Similar Companies
Medivir AB (publ) (0GP7.L)
YAKUODO HOLDINGS Co., Ltd. (7679.T)
ANG Lifesciences India Limited (ANG.BO)
EGF Theramed Health Corp. (EVAHF)
Inyx, Inc. (IYXI)
Bayer AG (BAY.WA)
Business
Sundrug Co., Ltd. (9989:TYO; SDGCF:OTCPK) operates drug stores, dispensing pharmacies, and discount stores primarily in Japan. The company conducts its activities through two main segments: the Drug Store Business, which sells pharmaceutical products including prescription and over-the-counter medications, cosmetics, daily necessities, and general merchandise; and the Discount Store Business, which offers food products, household goods, and sundry items. Sundrug Co., Ltd. serves retail customers across urban and suburban areas nationwide, with a network exceeding 950 stores focused on health, beauty, and convenience needs. Founded in 1957 by Yukimasa Tada and headquartered in Fuchu, Tokyo, Japan, the company maintains a strong emphasis on efficient supply chain management, customer loyalty programs, and digital enhancements such as e-commerce platforms and inventory systems. In recent developments, Sundrug Co., Ltd. reports robust financial performance for the six months ending September 30, 2025, with net sales growth of 5.8% year-over-year, alongside upward revisions to full-year forecasts and increased dividends. The company continues aggressive store expansion, adding approximately 50 locations annually, while investing in technology for improved operations and sustainability initiatives like plastic reduction. Earlier strategic moves include the 2022 acquisition of Daiya K.K. to bolster its retail footprint.